Newstrack India | Cadila Pharma launches new lung cancer drug The Hindu The new drug has been licensed and approved by the Drug Controller General of India (DCGI). Mycidac-C is meant for patients suffering from non-small cell lung cancer (NSCLC). “The drug is affordable, and is many times cheaper than what out competitors ... Ancestor of TB germ to fight lung cancer Cadila Pharma launches affordable drugs for lung cancer Cadila launches low-cost cancer drug |
